Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Non-small Cell Lung Cancer (NSCLC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic in Arizona - Phoenix ( Site 0147), Phoenix, Arizona, United States

    Study coordinator · 480-342-4800
  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130), Burbank, California, United States

    Study coordinator · 818-840-0921
  • Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132), Grand Junction, Colorado, United States

    Study coordinator · 970-298-7638
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0133), Jacksonville, Florida, United States

    Study coordinator · 904-953-9945
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0106), Marietta, Georgia, United States

  • The University of Louisville, James Graham Brown Cancer Center ( Site 0121), Louisville, Kentucky, United States

  • New England Cancer Specialists ( Site 0143), Westbrook, Maine, United States

    Study coordinator · 207-303-3424
  • University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144), Worcester, Massachusetts, United States

  • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115), Minneapolis, Minnesota, United States

    Study coordinator · 651-241-7025
  • Mayo Clinic - Rochester ( Site 0148), Rochester, Minnesota, United States

    Study coordinator · 507-538-1665
  • Hattiesburg Clinic Hematology/Oncology ( Site 0104), Hattiesburg, Mississippi, United States

    Study coordinator · 601-261-1700
  • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0134), Reno, Nevada, United States

    Study coordinator · 775-982-5050
  • University Hospitals Cleveland Medical Center ( Site 0119), Cleveland, Ohio, United States

  • Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0117), Corvallis, Oregon, United States

    Study coordinator · 541-768-4950
  • Oncology Consultants P.A. ( Site 0129), Houston, Texas, United States

  • Instituto Alexander Fleming ( Site 0306), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +54 9 011-3221-8900
  • Hospital Británico de Buenos Aires-Oncology ( Site 0304), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541143096807
  • Centro Privado de RMI Río Cuarto S.A. II ( Site 0310), Río Cuarto, Córdoba Province, Argentina

    Study coordinator · +54351153819050
  • Instituto de Oncología de Rosario ( Site 0301), Rosario, Santa Fe Province, Argentina

    Study coordinator · +549-341-5778394
  • Hospital Aleman-Oncology ( Site 0300), Buenos Aires, Argentina

    Study coordinator · +541148277000
  • Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3002), Port Macquarie, New South Wales, Australia

    Study coordinator · +61265801820
  • Westmead Hospital ( Site 3000), Westmead, New South Wales, Australia

    Study coordinator · +61247343500
  • Grampians Health-Medical Oncology ( Site 3001), Ballarat Central, Victoria, Australia

  • Northern Hospital ( Site 3003), Epping, Victoria, Australia

    Study coordinator · +61384058715
  • Peninsula University Hospital ( Site 3004), Frankston, Victoria, Australia

    Study coordinator · +61397847175
  • Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0409), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +55 51 3214 8151
  • Clinica Viver ( Site 0400), Santa Maria, Rio Grande do Sul, Brazil

    Study coordinator · +5555 30267720
  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0402), Barretos, São Paulo, Brazil

    Study coordinator · +551733216637
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0406), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · +551732015054
  • Instituto Nacional de Câncer - INCA ( Site 0405), Rio de Janeiro, Brazil

    Study coordinator · +552132076564
  • Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0401), São Paulo, Brazil

    Study coordinator · +551144500300
  • William Osler Health System ( Site 0203), Brampton, Ontario, Canada

    Study coordinator · 905-494-2120
  • Trillium Health Partners - Credit Valley Hospital ( Site 0202), Mississauga, Ontario, Canada

    Study coordinator · 905-813-1100x4299
  • McGill University Health Centre ( Site 0200), Montreal, Quebec, Canada

  • Clinica Universidad Catolica del Maule-Oncology ( Site 0501), Talca, Maule Region, Chile

    Study coordinator · 56947532700
  • Orlandi Oncologia-Oncology ( Site 0504), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56226057491
  • FALP-UIDO ( Site 0509), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56224205098
  • Bradfordhill-Clinical Area ( Site 0507), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56229490970
  • Bradford Hill Norte ( Site 0516), Antofagasta, Chile

    Study coordinator · 56442023631
  • Second Affiliated hospital of Anhui Medical University ( Site 3133), Hefei, Anhui, China

  • Beijing Cancer hospital-intrathoratic deparmtment II ( Site 3101), Beijing, Beijing Municipality, China

  • Beijing Peking Union Medical College Hospital-pneumology department ( Site 3100), Beijing, Beijing Municipality, China

  • Fujian Provincial Cancer Hospital ( Site 3131), Fuzhou, Fujian, China

    Study coordinator · 0591-83660063
  • The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 3107), Xiamen, Fujian, China

  • The First Affiliated Hospital of Guangzhou Medical University ( Site 3134), Guangzhou, Guangdong, China

  • Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 3108), Guangzhou, Guangdong, China

  • Affiliated Hospital of Guangdong Medical University ( Site 3123), Zhanjiang, Guangdong, China

  • The Second Hospital of Hebei Medical University ( Site 3135), Shijiazhuang, Hebei, China

    Study coordinator · 031166003872
  • Harbin Medical University Cancer Hospital-oncology of department ( Site 3132), Harbin, Heilongjiang, China

  • Henan Cancer Hospital ( Site 3116), Zhengzhou, Henan, China

  • Tongji Hospital Tongji Medical,Science & Technology ( Site 3117), Wuhan, Hubei, China

  • Wuhan Union Hospital ( Site 3130), Wuhan, Hubei, China

  • Hubei Cancer Hospital ( Site 3106), Wuhan, Hubei, China

  • Xiangyang Central Hospital-oncology department ( Site 3136), Xiangyang, Hubei, China

  • The Second Xiangya Hospital of Central South University ( Site 3138), Changsha, Hunan, China

  • Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3113), Wuxi, Jiangsu, China

  • The Affiliated Hospital of Xuzhou Medical College ( Site 3112), Xuzhou, Jiangsu, China

  • The First Affiliated Hospital of Nanchang University-Respiratory Medicine Department ( Site 3127), Nanchang, Jiangxi, China

  • The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 3121), Nanchang, Jiangxi, China

  • Jiangxi Provincial Cancer Hospital ( Site 3143), Nanchang, Jiangxi, China

  • Jilin Province Tumor Hospital-oncology department ( Site 3126), Changchun, Jilin, China

  • Jinan Central Hospital-oncology department ( Site 3122), Jinan, Shandong, China

    Study coordinator · 0531-55739999
  • Shandong Cancer Hospital ( Site 3119), Jinan, Shandong, China

  • Shanghai Changhai Hospital ( Site 3125), Shanghai, Shanghai Municipality, China

  • West China Hospital, Sichuan University ( Site 3124), Chengdu, Sichuan, China

  • Sichuan Cancer hospital. ( Site 3105), Chengdu, Sichuan, China

  • The Second People's Hospital of Neijiang ( Site 3140), Neijiang, Sichuan, China

  • Yunnan Province Cancer Hospital ( Site 3139), Kunming, Yunnan, China

  • The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115), Hangzhou, Zhejiang, China

  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3111), Hangzhou, Zhejiang, China

  • Taizhou Hospital of Zhejiang Province-Respiratory ( Site 3114), Taizhou, Zhejiang, China

  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0600), Bogotá, Bogota D.C., Colombia

    Study coordinator · 3219198898
  • IMAT S.A.S ( Site 0602), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +57 (3135342052)
  • Oncologos del Occidente ( Site 0603), Pereira, Risaralda Department, Colombia

    Study coordinator · 573002558656
  • Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1103), Ostrava, Ostrava Mesto, Czechia

    Study coordinator · +420 595 633 400
  • Multiscan-Onkologicke a radiologicke centrum Multiscan Pardubice ( Site 1105), Pardubice, Pardubice Region, Czechia

    Study coordinator · +420466016436
  • Vseobecna fakultni nemocnice v Praze-Onkologicka klinika ( Site 1106), Prague, Praha 2, Czechia

    Study coordinator · +420224962143
  • Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 1102), Olomouc, Czechia

    Study coordinator · +420 588 443 666
  • Regionshospitalet Gødstrup-Kræftklinikken ( Site 1204), Herning, Central Jutland, Denmark

    Study coordinator · +45 78430453
  • Aalborg Universitetshospital, Syd-Department of Oncology ( Site 1201), Aalborg, North Denmark, Denmark

    Study coordinator · +45 97660000
  • Odense Universitetshospital ( Site 1200), Odense, Region Syddanmark, Denmark

    Study coordinator · +4523612809
  • Hôpital Saint Joseph-ONCOLOGY ( Site 1308), Marseille, Bouches-du-Rhone, France

    Study coordinator · +33491806500
  • Institut Régional du Cancer Montpellier-Medical Oncology ( Site 1309), Montpellier, Herault, France

    Study coordinator · +33467613100
  • Centre Hospitalier Universitaire de Limoges - Hôpital Dupuyt-Unité d'oncologie thoracique et cutané ( Site 1303), Limoges, Limousin, France

    Study coordinator · +33555056892
  • Centre d'Oncologie de Gentilly ( Site 1301), Nancy, Meurthe-et-Moselle, France

    Study coordinator · 0033355685518
  • Centre Hospitalier de la Cote Basque ( Site 1300), Bayonne, Pyrenees-Atlantiques, France

    Study coordinator · 33559443172
  • L HOPITAL NORD OUEST ( Site 1310), Villefranche-sur-Saône, Rhone, France

    Study coordinator · +33642346915
  • Clinique de l'Europe-Service de pneumologie ( Site 1304), Amiens, Somme, France

    Study coordinator · 00 33 3 23 06 72 24
  • Centre Hospitalier Universitaire de Poitiers-Pôle régional de cancérologie ( Site 1305), Poitiers, Vienne, France

    Study coordinator · 00330516604212
  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Medizinische Klinik V ( Site 1409), München, Bavaria, Germany

  • Klinikum Bogenhausen-Klinik für Pneumologie und Onkologische Pneumologie ( Site 1406), München, Bavaria, Germany

    Study coordinator · 0049892704316
  • Klinikum Nürnberg Nord-5. Med. Klinik ( Site 1407), Nuremberg, Bavaria, Germany

    Study coordinator · +49 9113982674
  • Universitätsklinikum Marburg-Comprehensive Cancer Center ( Site 1412), Marburg, Hesse, Germany

    Study coordinator · +4964215861819
  • Medizinische Hochschule Hannover-Department of Pneumology ( Site 1411), Hanover, Lower Saxony, Germany

    Study coordinator · 49 511 532 6553
  • Bethanien Krankenhaus Moers ( Site 1400), Moers, North Rhine-Westphalia, Germany

    Study coordinator · +49 2841 200 2297
  • Universitätsklinikum Münster - Albert Schweitzer Campus-Medizinische Klinik A ( Site 1410), Münster, North Rhine-Westphalia, Germany

    Study coordinator · +49 251 83-52712
  • Universitätsmedizin Johannes Gutenberg Universität Mainz- Klinik für Pneumologie ( Site 1404), Mainz, Rhineland-Palatinate, Germany

    Study coordinator · +496131177031
  • LungenClinic Grosshansdorf-Onkologie ( Site 1401), Großhansdorf, Schleswig-Holstein, Germany

    Study coordinator · +49 4102 6012421
  • SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1403), Gera, Thuringia, Germany

    Study coordinator · 00493658287758
  • Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1402), Berlin, Germany

    Study coordinator · +4930450553044
  • Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1804), Bari, Apulia, Italy

    Study coordinator · +390805555442
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1807), Meldola, Emilia-Romagna, Italy

    Study coordinator · +390543739100
  • P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1803), Udine, Friuli Venezia Giulia, Italy

    Study coordinator · +390432552751
  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1800), Milan, Lombardy, Italy

    Study coordinator · +390223903813
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1810), Bergamo, Italy

    Study coordinator · +390352673687
  • AOU Renato Dulbecco ( Site 1801), Catanzaro, Italy

    Study coordinator · +390961883221
  • Azienda Ospedaliera Universitaria Careggi ( Site 1809), Florence, Italy

    Study coordinator · +390557947298
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1806), Roma, Italy

    Study coordinator · +390630154844
  • Fujita Health University Hospital ( Site 3411), Toyoake, Aichi-ken, Japan

    Study coordinator · +81-562-93-2111
  • Hirosaki University Hospital ( Site 3429), Hirosaki, Aomori, Japan

    Study coordinator · +81-172-33-5111
  • National Cancer Center Hospital East ( Site 3403), Kashiwa, Chiba, Japan

    Study coordinator · +81-4-7133-1111
  • National Hospital Organization Shikoku Cancer Center ( Site 3415), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • National Hospital Organization Kyushu Cancer Center ( Site 3417), Fukuoka, Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Kurume University Hospital ( Site 3418), Kurume, Fukuoka, Japan

    Study coordinator · +81-942-35-3311
  • Gunma Prefectural Cancer Center ( Site 3402), Ōta, Gunma, Japan

    Study coordinator · +81-276-38-0771
  • National Hospital Organization Himeji Medical Center ( Site 3426), Himeji, Hyōgo, Japan

    Study coordinator · +81-79-225-3211
  • Iwate Medical University Hospital ( Site 3428), Shiwa-gun, Iwate, Japan

    Study coordinator · +81-19-613-7111
  • St. Marianna University Hospital ( Site 3421), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Yokohama Municipal Citizen's Hospital ( Site 3425), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-316-4580
  • Kanagawa Cancer Center ( Site 3408), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Saiseikai Matsusaka Municipal Hospital ( Site 3422), Matsusaka, Mie-ken, Japan

    Study coordinator · +81-598-23-1515
  • Tohoku University Hospital ( Site 3424), Sendai, Miyagi, Japan

    Study coordinator · +81-22-717-7000
  • Sendai Kousei Hospital ( Site 3400), Sendai, Miyagi, Japan

    Study coordinator · +81-22-728-8000
  • Kansai Medical University Hospital ( Site 3412), Hirakata, Osaka, Japan

    Study coordinator · +81-72-804-0101
  • Osaka Medical and Pharmaceutical University Hospital ( Site 3413), Takatsuki, Osaka, Japan

    Study coordinator · +81-72-683-1221
  • National Hospital Organization Ureshino Medical Center ( Site 3427), Ureshino, Saga-ken, Japan

    Study coordinator · +81-954-43-1120
  • Niigata Cancer Center Hospital ( Site 3409), Niigata, Saitama, Japan

    Study coordinator · +81-25-266-5111
  • Shizuoka Cancer Center ( Site 3410), Suntogun, Shizuoka, Japan

    Study coordinator · +81-55-989-5222
  • Dokkyo Medical University Hospital ( Site 3401), Shimotsugagun, Tochigi, Japan

    Study coordinator · +81-282-86-1111
  • Tokyo Metropolitan Komagome Hospital ( Site 3405), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3823-2101
  • Cancer Institute Hospital of JFCR ( Site 3404), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Toho University Omori Medical Center ( Site 3420), Ōta-ku, Tokyo, Japan

    Study coordinator · +81-3-3762-4151
  • Tokyo Medical University Hospital ( Site 3407), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • National Center for Global Health and Medicine ( Site 3406), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3202-7181
  • National Hospital Organization Yamaguchi Ube Medical Center ( Site 3423), Ube, Yamaguchi, Japan

    Study coordinator · +81-836-58-2300
  • National Hospital Organization Kyushu Medical Center ( Site 3416), Fukuoka, Japan

    Study coordinator · +81-92-852-0700
  • Saiseikai Kumamoto Hospital ( Site 3419), Kumamoto, Japan

    Study coordinator · +81-96-351-8000
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 3414), Osaka, Japan

    Study coordinator · +81-6-6945-1181
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 0715), Guadalajara, Jalisco, Mexico

    Study coordinator · 3330447001
  • Higiea Oncologia ( Site 0721), Mexico City, Mexico City, Mexico

    Study coordinator · 5552731712
  • Axis Heilsa S. de R.L. de C.V. ( Site 0719), Monterrey, Nuevo León, Mexico

  • Centro de Atención e Investigación Cardiovascular del Potosí ( Site 0713), San Luis Potosí City, San Luis Potosí, Mexico

    Study coordinator · +52 444 585 2263
  • Oaxaca Site Management Organization S.C. ( Site 0718), Oaxaca City, Mexico

    Study coordinator · +529511301554
  • Clinica Integral Internacional de Oncología ( Site 0714), Puebla City, Mexico

    Study coordinator · +522223555576
  • Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 1901), Breda, North Brabant, Netherlands

    Study coordinator · 0031765955349
  • ETZ Elisabeth-Department of Pulmonary Diseases ( Site 1902), Tilburg, North Brabant, Netherlands

    Study coordinator · 0031132213101
  • Isala, locatie Zwolle-Poli Longziekten ( Site 1903), Zwolle, Overijssel, Netherlands

    Study coordinator · 0031886243254
  • Clinica Vallesur - AUNA ( Site 0854), Arequipa, Ariqipa, Peru

    Study coordinator · +51 926 938 398
  • Detecta Clínica ( Site 0853), Surquillo, Muni Metro de Lima, Peru

    Study coordinator · +51992783190
  • IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0851), Lima, Peru

    Study coordinator · +51 956754968
  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0850), Lima, Peru

    Study coordinator · +51940238282
  • Instituto Neuro Cardiovascular de las Americas ( Site 0856), Lima, Peru

    Study coordinator · +51991366612
  • Hospital Cayetano Heredia-Oncology ( Site 0855), Lima, Peru

    Study coordinator · +51 986981097
  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2003), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

    Study coordinator · 523743589
  • Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 2013), Grudziądz, Kuyavian-Pomeranian Voivodeship, Poland

  • Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 2016), Torun, Kuyavian-Pomeranian Voivodeship, Poland

  • Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 2015), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · 12 646 82 85
  • Instytut Gruzlicy i Chorob Pluc w Warszawie ( Site 2011), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · 00 48 22 431 22 79
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225462248
  • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001), Przemyśl, Podkarpackie Voivodeship, Poland

    Study coordinator · 16 677 55 10
  • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 2018), Olsztyn, Warmian-Masurian Voivodeship, Poland

    Study coordinator · +48895322978
  • SPZOZ Uniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej UM W Łodzi Centralny Szpital ( Site 2012), Lodz, Łódź Voivodeship, Poland

    Study coordinator · +48602181049
  • Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 2104), Lisbon, Lisbon District, Portugal

    Study coordinator · 00351217229800
  • Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2101), Lisbon, Lisbon District, Portugal

    Study coordinator · 00351217805000
  • Hospital Dr. Nélio Mendonça ( Site 2105), Funchal, Madeira, Portugal

    Study coordinator · +351291705600
  • Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 2103), Vila Nova de Gaia, Porto District, Portugal

  • Hospital CUF - Tejo ( Site 2100), Lisbon, Portugal

    Study coordinator · +351213926100
  • Wonju Severance Christian Hospital ( Site 3808), Wŏnju, Kang-won-do, South Korea

  • National Cancer Center ( Site 3801), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · +82319200406
  • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3800), Suwon, Kyonggi-do, South Korea

    Study coordinator · 82-31-249-7744
  • Ajou University Hospital-Hematology-Oncology ( Site 3806), Suwon, Kyonggi-do, South Korea

  • Chungbuk National University Hospital-Internal medicine ( Site 3804), Cheongju-si, North Chungcheong, South Korea

    Study coordinator · 82-43-269-6015
  • Keimyung University Dongsan Hospital CRC room 1 ( Site 3807), Daegu, Taegu-Kwangyokshi, South Korea

    Study coordinator · 82532586671
  • Asan Medical Center-Lung Cancer Center ( Site 3805), Seoul, South Korea

    Study coordinator · 02-3010-5419
  • Samsung Medical Center-Division of Hematology/Oncology ( Site 3802), Seoul, South Korea

    Study coordinator · 82-2-3410-3453
  • Hospital Jerez de la Frontera-UGC Oncología ( Site 2333), Jerez de la Frontera, Cadiz, Spain

    Study coordinator · +3485681420
  • CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 2335), A Coruña, La Coruna, Spain

    Study coordinator · 34981178000x292872
  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2331), Pozuelo de Alarcón, Madrid, Spain

    Study coordinator · +34914521987
  • H.R.U Malaga - Hospital General ( Site 2332), Málaga, Malaga, Spain

    Study coordinator · +34 95 130 81 30
  • Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2336), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · +34961114229
  • Hospital Universitari Vall d'Hebron-Oncology ( Site 2330), Barcelona, Spain

    Study coordinator · +34932746000
  • Hospital La Princesa ( Site 2338), Madrid, Spain

    Study coordinator · +34915202200
  • Hospital Universitario Nuestra Senora de la Candelaria ( Site 2339), Santa Cruz de Tenerife, Spain

    Study coordinator · 922602020
  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 2337), Seville, Spain

    Study coordinator · +34955013068
  • Chi Mei Hospital - Liouying Branch ( Site 3908), Tainan, Tainan, Taiwan

    Study coordinator · +886963051211
  • National Taiwan University Cancer Center (NTUCC) ( Site 3907), Taipei City, Taipei, Taiwan

    Study coordinator · +886223123456x267511
  • National Taiwan University Hospital - Hsinchu branch ( Site 3901), Hsinchu, Taiwan

    Study coordinator · +886-972-651-703
  • Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 3904), Kaohsiung City, Taiwan

  • Chang Gung Memorial Hospital at Kaohsiung ( Site 3902), Kaohsiung City, Taiwan

    Study coordinator · 88677317123
  • Taipei Medical University Shuang Ho Hospital ( Site 3912), New Taipei City, Taiwan

    Study coordinator · +886970746943
  • Taichung Veterans General Hospital-Chest ( Site 3905), Taichung, Taiwan

  • National Cheng Kung University Hospital-Clinical Trial Center ( Site 3903), Tainan, Taiwan

    Study coordinator · 88662353535
  • Chi Mei Medical Center ( Site 3915), Tainan, Taiwan

    Study coordinator · +886980195306
  • National Taiwan University Hospital-Oncology ( Site 3906), Taipei, Taiwan

  • Mackay Memorial Hospital ( Site 3909), Taipei, Taiwan

    Study coordinator · +886975835146
  • Faculty of Medicine Siriraj Hospital ( Site 4000), Bangkok, Bangkok, Thailand

    Study coordinator · +6624194489
  • Chulalongkorn University ( Site 4003), Pathumwan, Bangkok, Thailand

    Study coordinator · +6622564533
  • Maharaj Nakorn Chiang Mai Hospital-Chiang Mai Clinical Trial Unit (CM-CTU) ( Site 4001), Chiang Mai, Thailand

    Study coordinator · +6653935480
  • Medipol Mega Universite Hastanesi-oncology ( Site 2508), Stanbul, Istanbul, Turkey (Türkiye)

    Study coordinator · +90 5325280486
  • Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2503), Bornova, İzmir, Turkey (Türkiye)

    Study coordinator · 0090 232 390 43 34
  • Erciyes University ( Site 2511), Talas, Kayseri, Turkey (Türkiye)

    Study coordinator · +90 207 666 6270
  • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2507), Adana, Turkey (Türkiye)

    Study coordinator · +905056166338
  • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi-oncology ( Site 2506), Ankara, Turkey (Türkiye)

    Study coordinator · +903123360909
  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 2501), Ankara, Turkey (Türkiye)

    Study coordinator · +903123052841
  • Memorial Ankara Hastanesi-Medical Oncology ( Site 2505), Ankara, Turkey (Türkiye)

    Study coordinator · +90 5067521275
  • Ankara Bilkent Şehir Hastanesi ( Site 2500), Ankara, Turkey (Türkiye)

    Study coordinator · +903125526000
  • Pamukkale University Medical Faculty, Fahri Goksin Oncology Centre-Oncolgyy-Hematology ( Site 2510), Denizli, Turkey (Türkiye)

    Study coordinator · 0090 258 296 5142
  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2502), Istanbul, Turkey (Türkiye)

    Study coordinator · +902166065200
  • Ondokuz Mayıs Universitesi ( Site 2509), Samsun, Turkey (Türkiye)

    Study coordinator · +90 362 312 1919
  • Royal Free Hospital ( Site 2601), London, England, United Kingdom

    Study coordinator · 0207 794 0500
  • Queen Alexandra Hospital-Oncology Department ( Site 2603), Portsmouth, Hampshire, United Kingdom

    Study coordinator · 023 9228 6000 x4078
  • Kent and Canterbury Hospital-Oncology Research ( Site 2606), Canterbury, Kent, United Kingdom

    Study coordinator · 01227 866393
  • Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 2605), London, London, City of, United Kingdom

    Study coordinator · 0207 188 2006
  • James Cook University Hospital ( Site 2604), Central Middlesbrough, Middlesbrough, United Kingdom

    Study coordinator · +4401642837193
  • National Lung Hospital-Oncology Department ( Site 4175), Hanoi, Hanoi, Vietnam

  • Tam Anh General Hospital ( Site 4179), Hanoi, Hanoi, Vietnam

  • Cho Ray Hospital ( Site 4171), Ho Chi Minh, Hanoi, Vietnam

  • K Hospital - National Cancer Hospital ( Site 4174), Hà Nội, Vietnam

  • Ho Chi Minh City Oncology Hospital - Tan Phu Ward ( Site 4173), Ho Chi Minh City, Vietnam

  • Thong Nhat Hospital ( Site 4170), Ho Chi Minh City, Vietnam

מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC